phosphorylcholine has been researched along with valsartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, C; He, H; Jiang, L; Li, F; Liu, M; Mao, J; Yang, M | 1 |
| Feng, H; Li, WJ; Liao, HH; Mou, SQ; Tang, QZ; Wu, HM; Xia, H; Zhang, N; Zhou, ZY | 1 |
2 other study(ies) available for phosphorylcholine and valsartan
| Article | Year |
|---|---|
Understanding the interaction between valsartan and detergents by NMR techniques and molecular dynamics simulation.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cell Membrane; Cetrimonium; Cetrimonium Compounds; Detergents; Magnetic Resonance Spectroscopy; Micelles; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Phosphorylcholine; Polysorbates; Sodium Dodecyl Sulfate; Tetrazoles; Thermodynamics; Valine; Valsartan | 2012 |
Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Glycogen Synthase Kinase 3 beta; Heart Failure; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Organ Size; Phosphorylcholine; Pressure; Proto-Oncogene Proteins c-akt; Signal Transduction; Valsartan | 2020 |